Major bleeding among patients with atrial fibrillation treated with rivaroxaban or warfarin in Sweden. Interim results from an on-going post-authorization study
Event:
ESC Congress 2016
Topic:
Medical treatment
Session:
Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation?